Trials / Completed
CompletedNCT00266643
Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pain
A Comparison of Strategies for Switching Patients From Amitriptyline to Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 205 (planned)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to compare the tolerability of different methods for switching from another medication to duloxetine for the management of diabetic nerve pain. The primary objective is to compare the most gradual method with the most abrupt method, to see if they have different tolerability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | duloxetine hydrochloride |
Timeline
- Start date
- 2005-12-01
- Completion
- 2007-04-01
- First posted
- 2005-12-19
- Last updated
- 2007-08-03
Locations
20 sites across 2 countries: United States, Puerto Rico
Source: ClinicalTrials.gov record NCT00266643. Inclusion in this directory is not an endorsement.